Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy. A multicenter, prospective, and observational study

dc.authoridBeypinar, Ismail/0000-0002-0853-4096
dc.contributor.authorAraz, M.
dc.contributor.authorKaraagac, M.
dc.contributor.authorKorkmaz, L.
dc.contributor.authorKoral, L.
dc.contributor.authorInci, F.
dc.contributor.authorBeypinar, I.
dc.contributor.authorUysal, M.
dc.date.accessioned2025-01-27T21:07:16Z
dc.date.available2025-01-27T21:07:16Z
dc.date.issued2018
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description43rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY
dc.description.abstract[Anstract Not Available]
dc.description.sponsorshipEuropean Soc Med Oncol,Japanese Soc Med Oncol
dc.identifier.endpage636
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpage636
dc.identifier.urihttps://hdl.handle.net/20.500.12428/27968
dc.identifier.volume29
dc.identifier.wosWOS:000459277304157
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.titleComparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy. A multicenter, prospective, and observational study
dc.typeConference Object

Dosyalar